Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.
about
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Short telomere length is associated with impaired cognitive performance in European ancestry cohorts.The preclinical Alzheimer cognitive composite: measuring amyloid-related declineAssociation of cancer history with Alzheimer's disease onset and structural brain changes.Association of lifetime intellectual enrichment with cognitive decline in the older population.Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.Word Recall: Cognitive Performance Within Internet SurveysGene-Environment Interplay in Physical, Psychological, and Cognitive Domains in Mid to Late Adulthood: Is APOE a Variability Gene?APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.Cognitive decline in the elderly after surgery and anaesthesia: results from the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort.Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer's disease.Clinical workout for the early detection of cognitive decline and dementia.Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women.In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and PsychosociaLack of effect of the apolipoprotein E ε4 genotype on cognition during healthy aging.
P2860
Q31147579-DC5C86E3-EE49-4416-BF9E-F88B24E1BB5CQ33635720-6AD7C902-40C3-4F79-840E-A66D0A4A2A2BQ34422469-2A4490D1-66BA-4783-A3D4-381FC106FD96Q34433766-D54C62B3-3EC4-4FF4-9E47-EBC0928AE7E4Q34703256-C4F67197-7CE2-4538-89AC-E524672118C6Q35119419-0BF55965-CB35-4F40-AABC-BEFB139DA791Q35995579-DC856C1E-9144-4639-AB38-6E1C2EBA1BDBQ36166476-6A047A06-D636-43D2-AEE2-E7894D0504F5Q36874130-B0CB9814-890B-46C9-B92A-2F3D581E93AFQ37044205-28DB41AC-A6CD-4F54-9673-1B16C6BC9B8CQ37557766-5E6B8084-C27D-4ABA-91D5-F3063243178EQ38252671-12576A16-EB4C-40FD-9452-7C03405394FEQ38255755-BFFB6FE1-8602-4936-B13E-CD304562BBFAQ38704916-00E0BBD4-973C-491C-91A0-417C0E374E6AQ39822613-351AD24E-5E11-4925-BF77-8D213100B240Q47564464-70CABDF9-26B0-4C0A-BB0B-9685FEBD2B40Q48659010-0FB954C4-4CCE-4B49-BD7E-DE195B489FBC
P2860
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@en
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@nl
type
label
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@en
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@nl
prefLabel
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@en
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@nl
P2093
P2860
P50
P356
P1433
P1476
Age and apolipoprotein E genot ...... ecline in nondemented elderly.
@en
P2093
David P Salmon
Jeffery L Cummings
Reisa A Sperling
Ronald G Thomas
P2860
P304
P356
10.1037/A0032707
P577
2013-07-01T00:00:00Z